Comparing accelerated approval packages for major AD antibodies

(Please use a modern browser to see the interactive version of this visualization)

*both Phase III Aduhelm trials were terminated based on futility analysis
**PDUFA date is the deadline by which the FDA must make a regulatory decision for a drug

Source: GlobalData

GlobalData